Clinical Trial: Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07657793) titled 'Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia' on June 15.

Brief Summary: The goal of this clinical trial is to learn if sirolimus, added to standard background therapy (corticosteroids and hydroxychloroquine), works to treat systemic lupus erythematosus-associated immune thrombocytopenia (SLE-ITP) in adults aged 18 to 65 years. The study also aims to evaluate the long-term effectiveness and safety of sirolimus over 48 weeks.

The main questions it aims to answer are:

1. Does sirolimus increase the overall response rate (complete or partial remission of thrombocytopenia) at 24 weeks comp...